Nicholas Jason Singer - Net Worth and Insider Trading
Nicholas Jason Singer Net Worth
The estimated net worth of Nicholas Jason Singer is at least $890,775 dollars as of 2024-05-08. Nicholas Jason Singer is the Director of Eterna Therapeutics Inc and owns about 388,036 shares of Eterna Therapeutics Inc (ERNA) stock worth over $890,775. Details can be seen in Nicholas Jason Singer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nicholas Jason Singer has not made any transactions after 2022-12-02 and currently still holds the listed stock(s).
Transaction Summary of Nicholas Jason Singer
Nicholas Jason Singer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nicholas Jason Singer owns 3 companies in total, including Eterna Therapeutics Inc (ERNA) , OTR Acquisition Corp (OTRA) , and OTR Acquisition Corp (OTRAU) .
Click here to see the complete history of Nicholas Jason Singer’s form 4 insider trades.
Insider Ownership Summary of Nicholas Jason Singer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ERNA | Eterna Therapeutics Inc | 2022-12-02 | director |
| OTRA | OTR Acquisition Corp | 2020-11-17 | director & Chief Executive Officer |
| OTRAU | OTR Acquisition Corp | 2020-11-17 | director & Chief Executive Officer |
Nicholas Jason Singer Latest Holdings Summary
Nicholas Jason Singer currently owns a total of 1 stock. Nicholas Jason Singer owns 388,036 shares of Eterna Therapeutics Inc (ERNA) as of December 2, 2022, with a value of $890,775.
Latest Holdings of Nicholas Jason Singer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ERNA | Eterna Therapeutics Inc | 2022-12-02 | 388,036 | 2.30 | 890,775 |
Holding Weightings of Nicholas Jason Singer
Nicholas Jason Singer Form 4 Trading Tracker
According to the SEC Form 4 filings, Nicholas Jason Singer has made a total of 1 transactions in Eterna Therapeutics Inc (ERNA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eterna Therapeutics Inc is the acquisition of 283,286 shares on December 2, 2022, which cost Nicholas Jason Singer around $929,178.
Insider Trading History of Nicholas Jason Singer
- 1
Nicholas Jason Singer Trading Performance
GuruFocus tracks the stock performance after each of Nicholas Jason Singer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nicholas Jason Singer is 13.64%. GuruFocus also compares Nicholas Jason Singer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nicholas Jason Singer within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nicholas Jason Singer's insider trading performs compared to the benchmark.
Performance of Nicholas Jason Singer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.42 | | | | | |
| Relative Return to S&P 500(%) | 3.28 | | | | | |
Nicholas Jason Singer Ownership Network
Nicholas Jason Singer Owned Company Details
What does Eterna Therapeutics Inc do?
Who are the key executives at Eterna Therapeutics Inc?
Nicholas Jason Singer is the director of Eterna Therapeutics Inc. Other key executives at Eterna Therapeutics Inc include 10 percent owner Charles Cherington , 10 percent owner Freebird Investments Llc , and 10 percent owner Freebird Partners Lp .
Eterna Therapeutics Inc (ERNA) Insider Trades Summary
Over the past 18 months, Nicholas Jason Singer made 1 insider transaction in Eterna Therapeutics Inc (ERNA) with a net purchase of 283,286. Other recent insider transactions involving Eterna Therapeutics Inc (ERNA) include a net purchase of 335,920 shares made by John D Halpern , a net purchase of 261,756 shares made by Charles Cherington ,
In summary, during the past 3 months, insiders sold 0 shares of Eterna Therapeutics Inc (ERNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eterna Therapeutics Inc (ERNA) were sold and 880,962 shares were bought by its insiders, resulting in a net purchase of 880,962 shares.
Eterna Therapeutics Inc (ERNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eterna Therapeutics Inc Insider Transactions
Nicholas Jason Singer Mailing Address
Above is the net worth, insider trading, and ownership report for Nicholas Jason Singer. You might contact Nicholas Jason Singer via mailing address: 1395 Brickell Avenue, Suite 800, Miami Fl 33131.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
